Navigation Links
Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases

BOSTON, Sept. 4 /PRNewswire/ -- The Cytokine Institute (TCI), a Los Angeles-based DNA and genomics research and consulting group, announced today the opening of a new office in the heart of Boston's legal and financial district. The organization measures and analyzes the effects of chemical and toxic exposures on human health and the environment. Through its Boston-based consulting arm, Green Reach Consulting, TCI now offers a range of business, financial, litigation, and industrial consulting services focused on toxic tort issues, as well as environmental, healthcare, chemical, and hazard management.

The Cytokine Institute, founded by medical toxicologist Bruce Gillis, M.D., M.P.H, pioneered the genomics-based technology, msds1(TM), in concert with the faculty and staff of the University of Illinois College of Medicine. The technology analyzes how 36,000 parameters of an individual's DNA are affected by specific chemicals -- including benzene, chromium, asbestos and formaldehyde.

It is the first DNA evidence of its kind to be used in civil court, enabling attorneys and judges to weed out baseless and frivolous lawsuits while providing scientific evidence in support of those who have in fact suffered injury. Companies facing class-action lawsuits are now benefiting from TCI's technology and protocols.

"For the first time, we can now apply an impartial methodology for providing scientifically-based evidence in liability and workers compensation cases," said Dr. Gillis. "By eliminating our justice system's dependence on circumstantial evidence and often-unreliable expert witnesses, the technology's potential benefits for healthcare, insurance and tort litigation are profound."

The technology is currently being used in numerous workers compensation cases pending in California. Insurers, chemical companies, law firms and the American Bar Association are carefully watching its development for further use in courtrooms around the country.

Gary M. Rodrigues has joined The Cytokine Institute and Green Reach Consulting as Executive Vice President and Chief Operating Officer. Having previously served as Senior Vice President and Managing Director of the Willis Group's Environmental Practice in North America, Mr. Rodrigues brings over 25 years of expertise in insurance and risk management regarding environmental, health, safety, and toxic tort issues. Prior to Willis, Mr. Rodrigues served as Partner in Arthur Andersen's US-based Environmental, Health, and Safety- liability-focused practice.

Also from Willis, Michael Roche joins Green Reach Consulting as Senior Vice President and Managing Director. An attorney by trade, Mr. Roche is a toxic tort, products liability and regulatory compliance specialist. Prior to joining Green Reach, he practiced tort and insurance coverage law at Burns & Levinson and Donovan Hatem in Boston.

With an M.D. degree from the University of Illinois College of Medicine, a M.P.H. degree from the Harvard University School of Public Health, and medical residencies in Occupational Medicine and Medical Toxicology and in Internal Medicine, Dr. Bruce Gillis brings over 30 years of medical expertise as founder and CEO of The Cytokine Institute.

The Cytokine Institute provides a variety of consulting services in the area of litigation support, risk management, human resources, medical toxicology and healthcare. The organization developed DNA-based technologies, which provide vital information that is germane to Material Safety Data Sheets, the recently enacted REACH protocol and numerous other international, and United States rules and regulations concerning potentially harmful substances.

CONTACT: For more information visit or contact Leslie Valenza at (202) 258-3223 or .

SOURCE The Cytokine Institute
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. EraGens Revolutionary Genomic-Based Technologies
2. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
3. Genomics researcher Hood joins NimbleGen board
4. GE Healthcare partners with genomics institute
5. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
6. Control Your siRNA Research
7. Getting Started with MicroRNA Research
8. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
9. Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
10. Research Organics
11. A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015  AbbVie, is introducing Good ... on a daily routine for managing the life-long condition ... can affect the way the body absorbs it so ... a daily routine are important. The goal of the ... better manage their hypothyroidism by establishing a daily routine, ...
(Date:11/30/2015)... CA (PRWEB) , ... November ... ... Intelligence Company, today announced tighter software integration with MarkLogic, the Enterprise NoSQL ... organizations maximize information to drive change. , Smartlogic’s Content Intelligence capabilities provide ...
(Date:11/27/2015)... 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ... it has closed the sale of its global contrast ... NYSE Euronext) in a transaction valued at approximately $270 ... and a total of approximately 1,000 employees spread across ... St. Louis area. This entire workforce and ...
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
Breaking Biology Technology:
(Date:11/11/2015)... 11, 2015   MedNet Solutions , an innovative SaaS-based ... research, is pleased to announce that it will be a ... event, to be held November 17-19 in ... live demonstrations of iMedNet , MedNet,s easy-to-use, ... iMedNet has been able to deliver time and cost ...
(Date:11/9/2015)... , Nov. 09, 2015 ... the addition of the "Global Law ... their offering. --> ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
Breaking Biology News(10 mins):